Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 333

Similar articles for PubMed (Select 16954439)

2.
3.

p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.

Liang Y, Wu J, Stancel GM, Hyder SM.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):173-82. Epub 2005 Jan 28.

PMID:
15860260
4.

Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.

Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE.

Oncogene. 2005 Jan 27;24(5):790-800. Erratum in: Oncogene. 2005 Jun 9;24(25):4164.

PMID:
15592523
5.

Progestin regulation of vascular endothelial growth factor in human breast cancer cells.

Hyder SM, Murthy L, Stancel GM.

Cancer Res. 1998 Feb 1;58(3):392-5.

6.

Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.

Gee MF, Tsuchida R, Eichler-Jonsson C, Das B, Baruchel S, Malkin D.

Oncogene. 2005 Dec 1;24(54):8025-37.

PMID:
16116481
7.
9.

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.

Shirakami Y, Shimizu M, Adachi S, Sakai H, Nakagawa T, Yasuda Y, Tsurumi H, Hara Y, Moriwaki H.

Cancer Sci. 2009 Oct;100(10):1957-62. doi: 10.1111/j.1349-7006.2009.01241.x. Epub 2009 Jun 4.

PMID:
19558547
10.

Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts.

Sasaki T, Tanno S, Shibukawa K, Osanai S, Kawabe J, Ohsaki Y.

Int J Oncol. 2008 Sep;33(3):525-32.

PMID:
18695882
11.

The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.

Wu Y, Hooper AT, Zhong Z, Witte L, Bohlen P, Rafii S, Hicklin DJ.

Int J Cancer. 2006 Oct 1;119(7):1519-29.

PMID:
16671089
12.

Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.

Fitzpatrick TE, Lash GE, Yanaihara A, Charnock-Jones DS, Macdonald-Goodfellow SK, Graham CH.

Exp Cell Res. 2003 Feb 15;283(2):247-55.

PMID:
12581744
13.

Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.

Weigand M, Hantel P, Kreienberg R, Waltenberger J.

Angiogenesis. 2005;8(3):197-204. Epub 2005 Nov 19.

PMID:
16328160
15.

An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.

Aesoy R, Sanchez BC, Norum JH, Lewensohn R, Viktorsson K, Linderholm B.

Mol Cancer Res. 2008 Oct;6(10):1630-8. doi: 10.1158/1541-7786.MCR-07-2172.

16.

Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.

Li M, Yang H, Chai H, Fisher WE, Wang X, Brunicardi FC, Yao Q, Chen C.

Cancer. 2004 Nov 15;101(10):2341-50.

17.

Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells.

Carroll CE, Ellersieck MR, Hyder SM.

Menopause. 2008 May-Jun;15(3):570-4. doi: 10.1097/gme.0b013e31814fae5d.

PMID:
18467956
18.
20.

Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.

Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang X, Zheng X, Mikkelsen T, Jiang H, Chopp M.

J Exp Ther Oncol. 2007;6(3):219-29.

PMID:
17552362
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk